Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to November 2026.

37,449
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,872
Class I recallsReasonable probability of serious health consequences
24,509
Class II recallsTemporary or medically reversible health consequences
2,932
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,096 recalls
Most affected stateHawaii 200 recalls mention this state

Advertisement

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,956 recalls have been announced year to date.
  • Oct 2026 was 4% higher than the previous complete period (Sep 2026: 209).
  • The highest complete period was Jun 2026 (300).
  • Nov 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,509
Class I9,872
Class III2,932
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,509
Class I9,872
Class III2,932
Not Yet Classified2

Showing 12,041–12,060 of 21,307 recalls

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

HCG Reconstitued 6000 IU Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1739-06

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Published
November 7, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

HCG Reconstitued 50,000 IU Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1736-50

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Published
November 7, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

HCG Lyophilized 5000 IU Injectable Pharm D Solutions, Houston, Texas ---- NDC 69699-1707-10

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Published
November 7, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Glycerin 72% (Lidocaine/Epi 2:1) Injectable, Pharm D Solutions, Houston, Texas ---- NDC 69699-1401-30

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Published
November 7, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Glutathione 200 mg/mL Solution, Pharm D Solutions, Houston, Texas --- NDC 69699-1504-30

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Published
November 7, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Glutamine 10 mg/mL Solution, Pharm D Solutions, Houston, Texas ---- NDC 69699-1439-59

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Published
November 7, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Epinepherine 1 mg/1 mL 3 mL Injectable Pharm D Solutions, Houston, Texas ---- NDC 69699-0109-03

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Published
November 7, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Epi-Shugarcaine Kit Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1409-60

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Published
November 7, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Dexpanthenol Injection, 250 mg/mL Pharm D Solutions, Houston, Texas --- NDC 69699-1610-30

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Published
November 7, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass III

Calcium Gluconate 2.5% a) 250 mL 25 mg/mL NDC 69699-0908-25; b) Nasal Spray 2.5 Inhal Soln. NDC 69699-0908-10; c) Nebulization Solution 2.5% Inhal. Soln NDC 69699-0908-10; d) Nebulization 250 mL 2.5% Inhal Soln NDC 69699-0908-25; e) Oral Spray 2.5% 2.5% Oral Soln NDC 69699-0917-60, Pharm D Solutions, Houston, Texas

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Published
November 7, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Calcium Gluconate 10%, 100 mg/mL Injectable, Pharm D Solutions, Houston, Texas ---- NDC 69699-0914-30

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Published
November 7, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Calcium Gluconate1% Eyewash 10 mg/mL, 125 mL bottles, Pharm D Solutions, Houston, Texas ---- NDC 69699-0906-12

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Published
November 7, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Calcium Gluconate 1% Eyewash Oph. Soln, 10 mg/mL, 1000 mL bottles, Pharm D Solutions, Houston, Texas ---- NDC 69699-0907-10

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Published
November 7, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Caffeine and Sodium Benzoate Injection 125 mg/125 mg/mL Injectable Pharm D Solutions, Houston, Texas ---- NDC 69699-1428-02

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Published
November 7, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Bi-Mix (Papaverine/Phentolamine 150 mg/5 mg) a) Injectable NDC 69699-1760-15; b) (LYO) Powder NDC 69699-1760-15, Pharm D Solutions, Houston, Texas

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Published
November 7, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Bi-Mix Injection (Alprostadil 80 mcg/Lidocaine 2 mg/mL) Pharm D Solutions, Houston, Texas --- NDC 69699-1317-03

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Published
November 7, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Bi-Mix Injection, (Alprostadil 40 mcg/Lidocaine 2 mg/mL) Pharm D Solutions, Houston, Texas --- NDC 69699-1305-03

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Published
November 7, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Bi-Mix Injection (Alprostadil 150 mcg/Lidocaine 2 mg/mL), Pharm D Solutions, Houston, Texas --- NDC 69699-1323-05

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Published
November 7, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Bacteriostatic Water for Injection 10 mL, Pharm D Solutions, Houston, Texas --- NDC 69699-1417-10

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Published
November 7, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Beta-complex B-1, B-6, B-3, B-12, B-5 100, 2.54 Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1611-30

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Published
November 7, 2018
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.